ResearchIn-Press PreviewGastroenterologyHepatology
Open Access | 10.1172/jci.insight.170320
1Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, United States of America
2Gastroenterology Research Unit, Mayo Clinic, Rochester, United States of America
3Physiology and Biomedical Engineering, Mayo Clinic, Rochester, United States of America
4Mayo Clinic, Rochester, United States of America
Find articles by
Jalan-Sakrikar, N.
in:
JCI
|
PubMed
|
Google Scholar
|
1Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, United States of America
2Gastroenterology Research Unit, Mayo Clinic, Rochester, United States of America
3Physiology and Biomedical Engineering, Mayo Clinic, Rochester, United States of America
4Mayo Clinic, Rochester, United States of America
Find articles by
Anwar, A.
in:
JCI
|
PubMed
|
Google Scholar
|
1Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, United States of America
2Gastroenterology Research Unit, Mayo Clinic, Rochester, United States of America
3Physiology and Biomedical Engineering, Mayo Clinic, Rochester, United States of America
4Mayo Clinic, Rochester, United States of America
Find articles by
Yaqoob, U.
in:
JCI
|
PubMed
|
Google Scholar
|
1Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, United States of America
2Gastroenterology Research Unit, Mayo Clinic, Rochester, United States of America
3Physiology and Biomedical Engineering, Mayo Clinic, Rochester, United States of America
4Mayo Clinic, Rochester, United States of America
Find articles by Gan, C. in: JCI | PubMed | Google Scholar
1Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, United States of America
2Gastroenterology Research Unit, Mayo Clinic, Rochester, United States of America
3Physiology and Biomedical Engineering, Mayo Clinic, Rochester, United States of America
4Mayo Clinic, Rochester, United States of America
Find articles by Lagnado, A. in: JCI | PubMed | Google Scholar
1Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, United States of America
2Gastroenterology Research Unit, Mayo Clinic, Rochester, United States of America
3Physiology and Biomedical Engineering, Mayo Clinic, Rochester, United States of America
4Mayo Clinic, Rochester, United States of America
Find articles by
Wixom, A.
in:
JCI
|
PubMed
|
Google Scholar
|
1Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, United States of America
2Gastroenterology Research Unit, Mayo Clinic, Rochester, United States of America
3Physiology and Biomedical Engineering, Mayo Clinic, Rochester, United States of America
4Mayo Clinic, Rochester, United States of America
Find articles by
Jurk, D.
in:
JCI
|
PubMed
|
Google Scholar
|
1Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, United States of America
2Gastroenterology Research Unit, Mayo Clinic, Rochester, United States of America
3Physiology and Biomedical Engineering, Mayo Clinic, Rochester, United States of America
4Mayo Clinic, Rochester, United States of America
Find articles by
Huebert, R.
in:
JCI
|
PubMed
|
Google Scholar
|
Published September 14, 2023 - More info
Cellular senescence and biliary fibrosis are prototypical features of obliterative cholangiopathies, such as Primary Sclerosing Cholangitis (PSC). Telomere dysfunction can lead to senescence either through telomere erosion or damaged telomeres. Our goal was to investigate a mechanistic relationship between telomere damage and biliary fibrosis in PSC. Telomere attrition was observed in the bile ducts of PSC patients along with a reduction in telomerase reverse transcriptase (TERT) expression compared to normal livers. Similarly, liver tissue from mice models of biliary fibrosis showed telomere attrition with increased damage at telomeres measured as telomere-associated foci (TAF). Cellular models of senescence induction increased the TAFs in cholangiocytes. This coincided with decreased TERT expression and increased senescence, which was rescued by modulating TERT levels. Epigenetic analysis revealed increased acquisition of repressive histone methylation at the TERT promoter which correlated with decreased TERT transcription. Cholangiocyte-selective deletion of TERT in mice exacerbated fibrosis whereas androgen therapy towards telomerase rescued liver fibrosis and liver function in genetic mouse model of PSC. Our results demonstrate a mechanistic role for telomere dysfunction in cellular senescence and fibrosis that characterize PSC. This suggests that PSC may be, in part, a telomere biology disorder, and identifies TERT as a potential therapeutic target.